Author

Sudha Khurana

Observed names: Khurana, Sudha, S Khurana

Observed institutions: University of Delhi, Genentech, Acerta Pharma BV (Netherlands), University of Cincinnati

OpenAlex ID: A5111890030

Exposure of Newborn Male and Female Rats to Environmental Estrogens: Delayed and Sustained Hyperprolactinemia and Alterations in Estrogen Receptor Expression**This work was supported by NIH Grants ES-09555, ES-10154, and CA-80920; March of Dimes Grant 6-FY98–0159; and a grant from the Pardee Foundation. Preliminary results of this investigation were presented at the 82nd Annual Meeting of The Endocrine Society, Toronto, Canada, June 2000.

2000 · Sudha Khurana, Sejal Ranmal, et al. · Endocrinology · 162

Heparin-Binding Property of Human Prolactin: A Novel Aspect of Prolactin Biology

1999 · Sudha Khurana, Robin Kuns, et al. · Endocrinology · 43

Proteolysis of Human Prolactin: Resistance to Cathepsin D and Formation of a Nonangiostatic, C-Terminal 16K Fragment by Thrombin1

1999 · Sudha Khurana, Karen Liby, et al. · Endocrinology · 40

Two Distinct Pituitary Cell Lines from Mouse Intermediate Lobe Tumors: A Cell that Produces Prolactin-Regulating Factor and a Melanotroph

1997 · Robert Hnasko, Sudha Khurana, et al. · Endocrinology · 32

CONTACT-03: Randomized, open-label phase III study of atezolizumab plus cabozantinib versus cabozantinib monotherapy following progression on/after immune checkpoint inhibitor (ICI) treatment in patients with advanced/metastatic renal cell carcinoma.

2021 · Sumanta K. Pal, Laurence Albiges, et al. · Journal of Clinical Oncology · 25

Stress Hormone Secretion and Gut Signal Transducer (stat) Proteins After Burn Injury in Rats

2001 · Olivier Thellin, Greg Noel, et al. · Shock · 15

Heterogeneity in buffalo pituitary prolactin

1997 · Sudha Khurana, K. Muralidhar · Molecular and Cellular Biochemistry · 10

A Phase 3 Trial Comparing the Efficacy and Safety of Acalabrutinib in Combination with Venetoclax with or without Obinutuzumab, Compared with Investigator's Choice of Chemoimmunotherapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) without Del(17p) or TP53 Mutation

2019 · Jennifer R Brown, Barbara F. Eichhorst, et al. · Blood · 8

Brain Prolactin

2002 · Nira Ben-Jonathan, Sudha Khurana, et al. · Elsevier eBooks · 5

CLL-092: Phase 3 Trial of Acalabrutinib in Combination with Venetoclax, With and Without Obinutuzumab Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

2020 · Jennifer R. Brown, Barbara Eichhorst, et al. · Clinical Lymphoma Myeloma & Leukemia · 2

Interim update of the ATRC-101 phase 1b trial in advanced solid tumors.

2023 · Bartosz Chmielowski, Saravut John Weroha, et al. · Journal of Clinical Oncology · 1

A possible urease-based homologous ELISA for buffalo prolactin.

1994 · S Khurana, S Kunchaparty, et al. · PubMed · 1

717 Interim clinical update of the phase 1b trial of ATRC-101 as monotherapy or in combination with pembrolizumab for select advanced solid tumors

2022 · Bartosz Chmielowski, John Weroha, et al. · Regular and Young Investigator Award Abstracts

The serum concentration of prolactin is suppressed and corticosterone is elevated in male rats following sublethal burn injury

2000 · Olivier Thellin, Greg Noel, et al. · Open Repository and Bibliography (University of Liège)

Works count: 16

Citation count: 344

H-index: 8

I10-index: 7